*** CHEMICAL IDENTIFICATION *** RTECS NUMBER : WM3380000 CHEMICAL NAME : Succinaldehydic acid CAS REGISTRY NUMBER : 692-29-5 BEILSTEIN REFERENCE NO. : 1745187 REFERENCE : 4-03-00-01554 (Beilstein Handbook Reference) LAST UPDATED : 199712 DATA ITEMS CITED : 4 MOLECULAR FORMULA : C4-H6-O3 MOLECULAR WEIGHT : 102.10 WISWESSER LINE NOTATION : VH2VQ COMPOUND DESCRIPTOR : Drug SYNONYMS/TRADE NAMES : * Butanoic acid, 4-oxo- * Butryaldehydic acid * 3-Formylpropanoic acid * beta-Formylpropionic acid * 3-Formylpropionic acid * 4-Oxobutanoic acid * gamma-Oxybutyric acid * Semi-aldehyde succinique * Succinic acid semialdehyde * Succinic semialdehyde *** HEALTH HAZARD DATA *** ** ACUTE TOXICITY DATA ** TYPE OF TEST : LD - Lethal dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : >3 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : FMXXAJ French Medicament Patent Document. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Discontinued. Volume(issue)/page/year: #3296M TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 1900 mg/kg TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - muscle weakness REFERENCE : PCJOAU Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1- 1967- Volume(issue)/page/year: 3,697,1969 TYPE OF TEST : LD - Lethal dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : >3 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : FMXXAJ French Medicament Patent Document. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Discontinued. Volume(issue)/page/year: #3296M TYPE OF TEST : LD - Lethal dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : >3 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : FMXXAJ French Medicament Patent Document. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Discontinued. Volume(issue)/page/year: #3296M *** END OF RECORD ***